×
Gortec
Presentation
Organizational chart
Mission
Professionals
Generalities
Next meeting
Board Early Assets
Gortec Journal
Publications
GORTEC
Meta-analysis publications
Clinical Trials
Ongoing Clinical Trials
Pending publications
Completed and published
Links
Select your language
Essais en cours
TATIANA (2024-01)
AdCC (2023-01)
XXL (2022-01)
GORTEC 2019-01
GORTEC 2018-02
GORTEC 2018-01
GORTEC 2018-03
GORTEC 2017-03
GORTEC 2017-02
GORTEC 2017-01
GORTEC 2016-02
GORTEC 2015-01
GORTEC 2014-04
GORTEC 2014-03
En attente de publication
ETUDES ELAN
GORTEC 2014-02
GORTEC 2013-01
GORTEC 2008-01
Terminés et publiés
Debio (1143-201)
GORTEC 2015-02
GORTEC 2010_02
IMPATOX
GORTEC 2014-01
GORTEC 2004-01
GORTEC 2007-01
GORTEC 2007-02
GORTEC 99-02
GORTEC 2005-01
GORTEC 94-01
GORTEC 94-02
GORTEC 98-01
GORTEC 2000-02
GORTEC 2004-02
GORTEC 2007
GORTEC 2006-01
GORTEC 2008-02
CIRCUTEC
GORTEC 2009-01
GORTEC 2008-03 TPEX
GORTEC NPC 2006
GORTEC 96-01 (VADN3)
GORTEC 98-02
GORTEC 2000-01
ADJORL1
Essais Intergroupe ORL
BEST OF
CHECKUp
IMMUQ
TORPHYNX
PATHOS
JANORL1
JANORL2
Essais Partenariat
OSKAR
Divers
Association patients
Home
Actualités
NIVOPOST-OP : GORTEC Announces New Trial Success for Head and Neck Cancer Treatment
NIVOPOST-OP : GORTEC Announces New Trial Success for Head and Neck Cancer Treatment
https://www.prnewswire.com/news-releases/gortec-announces-new-trial-success-for-head-and-neck-cancer-treatment-302344120.html
Copyright © 2024 GORTEC - Groupe d'Oncologie Radiothérapie Tête Et Cou
